chr16-2323686-C-T

Variant summary

Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1

The ENST00000301732.10(ABCA3):​c.450G>A​(p.Val150=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00654 in 1,614,074 control chromosomes in the GnomAD database, including 575 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.034 ( 302 hom., cov: 32)
Exomes 𝑓: 0.0037 ( 273 hom. )

Consequence

ABCA3
ENST00000301732.10 splice_region, synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.0740
Variant links:
Genes affected
ABCA3 (HGNC:33): (ATP binding cassette subfamily A member 3) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. The full transporter encoded by this gene may be involved in development of resistance to xenobiotics and engulfment during programmed cell death. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 16-2323686-C-T is Benign according to our data. Variant chr16-2323686-C-T is described in ClinVar as [Benign]. Clinvar id is 178701.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.074 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.115 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ABCA3NM_001089.3 linkuse as main transcriptc.450G>A p.Val150= splice_region_variant, synonymous_variant 7/33 ENST00000301732.10 NP_001080.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ABCA3ENST00000301732.10 linkuse as main transcriptc.450G>A p.Val150= splice_region_variant, synonymous_variant 7/331 NM_001089.3 ENSP00000301732 P1Q99758-1
ABCA3ENST00000382381.7 linkuse as main transcriptc.450G>A p.Val150= splice_region_variant, synonymous_variant 7/321 ENSP00000371818
ABCA3ENST00000567910.1 linkuse as main transcriptc.450G>A p.Val150= splice_region_variant, synonymous_variant 6/61 ENSP00000454397 Q99758-2
ABCA3ENST00000563623.5 linkuse as main transcriptn.1013G>A splice_region_variant, non_coding_transcript_exon_variant 7/201

Frequencies

GnomAD3 genomes
AF:
0.0340
AC:
5166
AN:
152138
Hom.:
301
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.118
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0124
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.000456
Gnomad OTH
AF:
0.0287
GnomAD3 exomes
AF:
0.00892
AC:
2244
AN:
251476
Hom.:
109
AF XY:
0.00636
AC XY:
865
AN XY:
135918
show subpopulations
Gnomad AFR exome
AF:
0.119
Gnomad AMR exome
AF:
0.00668
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000163
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000360
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00368
AC:
5377
AN:
1461818
Hom.:
273
Cov.:
31
AF XY:
0.00312
AC XY:
2268
AN XY:
727210
show subpopulations
Gnomad4 AFR exome
AF:
0.125
Gnomad4 AMR exome
AF:
0.00749
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.000243
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000263
Gnomad4 OTH exome
AF:
0.00808
GnomAD4 genome
AF:
0.0340
AC:
5179
AN:
152256
Hom.:
302
Cov.:
32
AF XY:
0.0331
AC XY:
2465
AN XY:
74454
show subpopulations
Gnomad4 AFR
AF:
0.118
Gnomad4 AMR
AF:
0.0124
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000456
Gnomad4 OTH
AF:
0.0284
Alfa
AF:
0.0144
Hom.:
65
Bravo
AF:
0.0400
Asia WGS
AF:
0.00808
AC:
28
AN:
3478
EpiCase
AF:
0.000218
EpiControl
AF:
0.000593

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 31, 2018This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Val150Val in exon 7 of ABCA3: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 11.3% (498/4396) of African American chromosomes from a broad population by the NHLBI Exome Sequenci ng Project (http://evs.gs.washington.edu/EVS; dbSNP rs74002800). -
Interstitial lung disease due to ABCA3 deficiency Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hereditary pulmonary alveolar proteinosis Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 29, 2016This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.36
CADD
Benign
8.0
DANN
Benign
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs74002800; hg19: chr16-2373687; API